Hydrolytically Degradable Poly(ethylene glycol) Derivatives for Use in Pharmaceutical Formulations
Tech ID: 22412 / UC Case 2012-315-0
Brief Description
A novel hydrolytically degradable polyethylene glycol derivative for use in pharmaceutical and cosmetic formulations.
Background
Polyethylene glycol (PEG) is a polyether compound with many applications from personal care to medicines. It is commonly attached to a drug or therapeutic protein in order to improve the bioavailability and associated stability of the drug. PEG in pharmaceutical applications is not usually degradable, narrowing the overall scope for its usage. Functionalization of PEG is also difficult as only the chain end groups can be exploited.
Description
Researchers at the University of California, Santa Barbara have developed a novel hydrolytically degradable polyethylene glycol derivative for use in pharmaceutical and cosmetic formulations. These PEG derivatives significantly boast control over the circulation half-life of PEG-incorporated drugs while allowing complete clearance from the body even at very high molecular weights. These PEG derivatives are simple and inexpensive to create with the degradable units further serving as reactive groups for therapeutic and diagnostic applications. These units also increase the range and overall number of functionalization sites, increasing pharmaceutical usefulness and patentability.
Advantages
- Excellent hydrolytic behavior
- Inexpensive and simple to manufacture
- Accurately controlled PEG molecular weight before and after degradation
- Degradable units serve as reactive groups for therapeutic and diagnostic applications
- Control over circulation half-life of PEG-incorporated drugs
Applications
- Pharmaceutical and cosmetic formulations
- Drug manufacturing and research
- Therapeutic drugs with improved circulation half-lives
- Controlled delivery of protein drugs.
This technology is available for licensing.
Patent Status
Patent Pending
Inventors
- Hawker, Craig J.
- Lee, Bongjae
- Lundberg, Pontus
- Lynd, Nathaniel A.
- Pressly, Eric D.
- van den Berg, Sebastiaan A.
Other Information
Categorized As
Related cases
2012-315-0
Keywords
PEG, Pharmaceutical, Diagnostic, Degradable, Drug
Contact
Shaun R. Juncal / juncal@tia.ucsb.edu / tel: View Phone Number. Please reference Tech ID #22412.
ADDITIONAL TECHNOLOGIES BY THESE INVENTORS
- Supramolecular Block Copolymer Compositions For Sub-Micron Lithography
- High Energy-Density Polymer Electrolytes for Batteries and Energy Storage
- High Performance Polymeric Material for Holographic Data Storage
- Reverse Photochromic Switch Compound for Opto-Mechanical Materials
- Highly Controllable Living Radical Polymerization Reactions for the Synthesis of Novel Polymers and Macromolecules
- High Performance Optical Encapsulant Resins for LED Devices
